Fluorine in PDB 5v8q: Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
Protein crystallography data
The structure of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III, PDB code: 5v8q
was solved by
K.P.Wilson,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
|
Resolution Low / High (Å)
|
36.15 /
1.44
|
|
Space group
|
P 21 21 21
|
|
Cell size a, b, c (Å), α, β, γ (°)
|
54.747,
65.557,
70.941,
90.00,
90.00,
90.00
|
|
R / Rfree (%)
|
16.7 /
20.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
(pdb code 5v8q). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III, PDB code: 5v8q:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5v8q
Go back to
Fluorine Binding Sites List in 5v8q
Fluorine binding site 1 out
of 6 in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
 Mono view
 Stereo pair view
|
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III within 5.0Å range:
|
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1004
b:18.3
occ:0.50
|
F21
|
A:97A1004
|
0.0
|
18.3
|
0.5
|
|
F21
|
A:97A1004
|
0.4
|
17.4
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.3
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.4
|
0.5
|
|
F23
|
A:97A1004
|
2.1
|
19.6
|
0.5
|
|
F23
|
A:97A1004
|
2.3
|
18.3
|
0.5
|
|
F22
|
A:97A1004
|
2.3
|
17.9
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.5
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.2
|
0.5
|
|
F22
|
A:97A1004
|
2.4
|
18.8
|
0.5
|
|
C19
|
A:97A1004
|
2.7
|
17.9
|
0.5
|
|
C19
|
A:97A1004
|
2.7
|
18.1
|
0.5
|
|
SD
|
A:MET787
|
3.3
|
23.4
|
1.0
|
|
CE1
|
A:PHE764
|
3.5
|
16.7
|
1.0
|
|
CD1
|
A:LEU873
|
3.6
|
20.7
|
1.0
|
|
C15
|
A:97A1004
|
3.6
|
17.9
|
0.5
|
|
C15
|
A:97A1004
|
3.7
|
17.8
|
0.5
|
|
CG2
|
A:VAL746
|
3.8
|
15.5
|
0.3
|
|
O10
|
A:97A1004
|
4.0
|
19.4
|
0.5
|
|
O10
|
A:97A1004
|
4.0
|
20.1
|
0.5
|
|
CG2
|
A:VAL746
|
4.1
|
18.4
|
0.7
|
|
C12
|
A:97A1004
|
4.1
|
18.1
|
0.5
|
|
CE
|
A:MET749
|
4.1
|
18.8
|
1.0
|
|
C12
|
A:97A1004
|
4.1
|
18.3
|
0.5
|
|
CE
|
A:MET787
|
4.1
|
22.8
|
1.0
|
|
C16
|
A:97A1004
|
4.2
|
18.0
|
0.5
|
|
CD1
|
A:PHE764
|
4.3
|
15.2
|
1.0
|
|
C16
|
A:97A1004
|
4.3
|
20.0
|
0.5
|
|
CB
|
A:VAL746
|
4.3
|
17.7
|
0.7
|
|
CA
|
A:VAL746
|
4.5
|
15.2
|
1.0
|
|
CZ
|
A:PHE764
|
4.5
|
16.6
|
1.0
|
|
CD2
|
A:LEU873
|
4.7
|
20.8
|
1.0
|
|
CB
|
A:VAL746
|
4.7
|
15.8
|
0.3
|
|
C14
|
A:97A1004
|
4.7
|
17.8
|
0.5
|
|
CG
|
A:LEU873
|
4.8
|
19.2
|
1.0
|
|
C14
|
A:97A1004
|
4.8
|
16.2
|
0.5
|
|
C9
|
A:97A1004
|
4.8
|
18.8
|
0.5
|
|
C9
|
A:97A1004
|
4.9
|
19.3
|
0.5
|
|
N
|
A:VAL746
|
4.9
|
14.2
|
1.0
|
|
N11
|
A:97A1004
|
4.9
|
19.2
|
0.5
|
|
C13
|
A:97A1004
|
4.9
|
18.9
|
0.5
|
|
N11
|
A:97A1004
|
4.9
|
19.1
|
0.5
|
|
C13
|
A:97A1004
|
4.9
|
17.6
|
0.5
|
|
N17
|
A:97A1004
|
5.0
|
19.7
|
0.5
|
|
CG
|
A:MET787
|
5.0
|
20.1
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5v8q
Go back to
Fluorine Binding Sites List in 5v8q
Fluorine binding site 2 out
of 6 in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
 Mono view
 Stereo pair view
|
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III within 5.0Å range:
|
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1004
b:17.4
occ:0.50
|
F21
|
A:97A1004
|
0.0
|
17.4
|
0.5
|
|
F21
|
A:97A1004
|
0.4
|
18.3
|
0.5
|
|
C20
|
A:97A1004
|
1.3
|
18.3
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.4
|
0.5
|
|
F22
|
A:97A1004
|
2.0
|
17.9
|
0.5
|
|
F22
|
A:97A1004
|
2.2
|
18.8
|
0.5
|
|
F23
|
A:97A1004
|
2.3
|
19.6
|
0.5
|
|
C18
|
A:97A1004
|
2.3
|
17.5
|
0.5
|
|
F23
|
A:97A1004
|
2.3
|
18.3
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.2
|
0.5
|
|
C19
|
A:97A1004
|
2.6
|
17.9
|
0.5
|
|
C19
|
A:97A1004
|
2.6
|
18.1
|
0.5
|
|
CD1
|
A:LEU873
|
3.4
|
20.7
|
1.0
|
|
SD
|
A:MET787
|
3.4
|
23.4
|
1.0
|
|
CG2
|
A:VAL746
|
3.5
|
15.5
|
0.3
|
|
C15
|
A:97A1004
|
3.6
|
17.9
|
0.5
|
|
C15
|
A:97A1004
|
3.7
|
17.8
|
0.5
|
|
CE1
|
A:PHE764
|
3.9
|
16.7
|
1.0
|
|
CG2
|
A:VAL746
|
4.0
|
18.4
|
0.7
|
|
O10
|
A:97A1004
|
4.0
|
19.4
|
0.5
|
|
C12
|
A:97A1004
|
4.0
|
18.1
|
0.5
|
|
C12
|
A:97A1004
|
4.0
|
18.3
|
0.5
|
|
O10
|
A:97A1004
|
4.1
|
20.1
|
0.5
|
|
CB
|
A:VAL746
|
4.2
|
17.7
|
0.7
|
|
C16
|
A:97A1004
|
4.2
|
18.0
|
0.5
|
|
C16
|
A:97A1004
|
4.3
|
20.0
|
0.5
|
|
CE
|
A:MET787
|
4.3
|
22.8
|
1.0
|
|
CA
|
A:VAL746
|
4.3
|
15.2
|
1.0
|
|
CE
|
A:MET749
|
4.3
|
18.8
|
1.0
|
|
CB
|
A:VAL746
|
4.5
|
15.8
|
0.3
|
|
CD1
|
A:PHE764
|
4.6
|
15.2
|
1.0
|
|
CD2
|
A:LEU873
|
4.6
|
20.8
|
1.0
|
|
CG
|
A:LEU873
|
4.6
|
19.2
|
1.0
|
|
N
|
A:VAL746
|
4.7
|
14.2
|
1.0
|
|
C14
|
A:97A1004
|
4.7
|
17.8
|
0.5
|
|
C14
|
A:97A1004
|
4.8
|
16.2
|
0.5
|
|
C9
|
A:97A1004
|
4.8
|
19.3
|
0.5
|
|
C9
|
A:97A1004
|
4.8
|
18.8
|
0.5
|
|
N11
|
A:97A1004
|
4.8
|
19.2
|
0.5
|
|
CZ
|
A:PHE764
|
4.8
|
16.6
|
1.0
|
|
SD
|
A:MET742
|
4.9
|
19.8
|
1.0
|
|
N11
|
A:97A1004
|
4.9
|
19.1
|
0.5
|
|
C13
|
A:97A1004
|
4.9
|
18.9
|
0.5
|
|
C13
|
A:97A1004
|
4.9
|
17.6
|
0.5
|
|
N17
|
A:97A1004
|
5.0
|
19.7
|
0.5
|
|
Fluorine binding site 3 out
of 6 in 5v8q
Go back to
Fluorine Binding Sites List in 5v8q
Fluorine binding site 3 out
of 6 in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
 Mono view
 Stereo pair view
|
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III within 5.0Å range:
|
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1004
b:17.9
occ:0.50
|
F22
|
A:97A1004
|
0.0
|
17.9
|
0.5
|
|
F22
|
A:97A1004
|
0.6
|
18.8
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.3
|
0.5
|
|
C20
|
A:97A1004
|
1.5
|
18.4
|
0.5
|
|
F21
|
A:97A1004
|
2.0
|
17.4
|
0.5
|
|
F21
|
A:97A1004
|
2.3
|
18.3
|
0.5
|
|
F23
|
A:97A1004
|
2.3
|
18.3
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.5
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.2
|
0.5
|
|
F23
|
A:97A1004
|
2.6
|
19.6
|
0.5
|
|
C19
|
A:97A1004
|
3.1
|
17.9
|
0.5
|
|
C19
|
A:97A1004
|
3.1
|
18.1
|
0.5
|
|
CG2
|
A:VAL746
|
3.2
|
15.5
|
0.3
|
|
N
|
A:VAL746
|
3.2
|
14.2
|
1.0
|
|
CB
|
A:MET745
|
3.3
|
16.4
|
1.0
|
|
C15
|
A:97A1004
|
3.3
|
17.8
|
0.5
|
|
C15
|
A:97A1004
|
3.3
|
17.9
|
0.5
|
|
CA
|
A:VAL746
|
3.5
|
15.2
|
1.0
|
|
C
|
A:MET745
|
3.5
|
14.5
|
1.0
|
|
C16
|
A:97A1004
|
3.6
|
20.0
|
0.5
|
|
C16
|
A:97A1004
|
3.6
|
18.0
|
0.5
|
|
CB
|
A:VAL746
|
3.7
|
17.7
|
0.7
|
|
O
|
A:MET742
|
3.9
|
15.2
|
1.0
|
|
O
|
A:MET745
|
3.9
|
16.3
|
1.0
|
|
CB
|
A:VAL746
|
3.9
|
15.8
|
0.3
|
|
CE
|
A:MET745
|
4.0
|
17.8
|
1.0
|
|
CA
|
A:MET745
|
4.0
|
15.1
|
1.0
|
|
CD1
|
A:LEU873
|
4.2
|
20.7
|
1.0
|
|
SD
|
A:MET742
|
4.2
|
19.8
|
1.0
|
|
N17
|
A:97A1004
|
4.2
|
23.4
|
0.5
|
|
CG2
|
A:VAL746
|
4.2
|
18.4
|
0.7
|
|
N17
|
A:97A1004
|
4.2
|
19.7
|
0.5
|
|
C12
|
A:97A1004
|
4.4
|
18.1
|
0.5
|
|
C12
|
A:97A1004
|
4.4
|
18.3
|
0.5
|
|
C14
|
A:97A1004
|
4.5
|
16.2
|
0.5
|
|
CG
|
A:MET745
|
4.5
|
17.1
|
1.0
|
|
C14
|
A:97A1004
|
4.5
|
17.8
|
0.5
|
|
SD
|
A:MET745
|
4.6
|
17.3
|
1.0
|
|
C
|
A:VAL746
|
4.9
|
14.9
|
1.0
|
|
C13
|
A:97A1004
|
4.9
|
17.6
|
0.5
|
|
C
|
A:MET742
|
4.9
|
15.4
|
1.0
|
|
N
|
A:MET745
|
4.9
|
14.3
|
1.0
|
|
C13
|
A:97A1004
|
4.9
|
18.9
|
0.5
|
|
CG1
|
A:VAL746
|
5.0
|
17.6
|
0.7
|
|
CG
|
A:MET742
|
5.0
|
17.5
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5v8q
Go back to
Fluorine Binding Sites List in 5v8q
Fluorine binding site 4 out
of 6 in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
 Mono view
 Stereo pair view
|
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III within 5.0Å range:
|
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1004
b:18.8
occ:0.50
|
F22
|
A:97A1004
|
0.0
|
18.8
|
0.5
|
|
F22
|
A:97A1004
|
0.6
|
17.9
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.3
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.4
|
0.5
|
|
F23
|
A:97A1004
|
1.8
|
18.3
|
0.5
|
|
F21
|
A:97A1004
|
2.2
|
17.4
|
0.5
|
|
F23
|
A:97A1004
|
2.3
|
19.6
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.2
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.5
|
0.5
|
|
F21
|
A:97A1004
|
2.4
|
18.3
|
0.5
|
|
CB
|
A:MET745
|
3.0
|
16.4
|
1.0
|
|
N
|
A:VAL746
|
3.0
|
14.2
|
1.0
|
|
C15
|
A:97A1004
|
3.1
|
17.8
|
0.5
|
|
C15
|
A:97A1004
|
3.1
|
17.9
|
0.5
|
|
C
|
A:MET745
|
3.1
|
14.5
|
1.0
|
|
C16
|
A:97A1004
|
3.2
|
20.0
|
0.5
|
|
C16
|
A:97A1004
|
3.2
|
18.0
|
0.5
|
|
CA
|
A:VAL746
|
3.3
|
15.2
|
1.0
|
|
C19
|
A:97A1004
|
3.4
|
17.9
|
0.5
|
|
C19
|
A:97A1004
|
3.4
|
18.1
|
0.5
|
|
O
|
A:MET745
|
3.4
|
16.3
|
1.0
|
|
CG2
|
A:VAL746
|
3.5
|
15.5
|
0.3
|
|
N17
|
A:97A1004
|
3.7
|
23.4
|
0.5
|
|
N17
|
A:97A1004
|
3.7
|
19.7
|
0.5
|
|
CA
|
A:MET745
|
3.7
|
15.1
|
1.0
|
|
CB
|
A:VAL746
|
3.8
|
17.7
|
0.7
|
|
CB
|
A:VAL746
|
4.0
|
15.8
|
0.3
|
|
CE
|
A:MET745
|
4.1
|
17.8
|
1.0
|
|
O
|
A:MET742
|
4.1
|
15.2
|
1.0
|
|
CG
|
A:MET745
|
4.3
|
17.1
|
1.0
|
|
CG2
|
A:VAL746
|
4.3
|
18.4
|
0.7
|
|
C14
|
A:97A1004
|
4.4
|
16.2
|
0.5
|
|
C14
|
A:97A1004
|
4.4
|
17.8
|
0.5
|
|
SD
|
A:MET745
|
4.4
|
17.3
|
1.0
|
|
C12
|
A:97A1004
|
4.6
|
18.1
|
0.5
|
|
CB
|
A:MET749
|
4.6
|
15.4
|
1.0
|
|
C12
|
A:97A1004
|
4.6
|
18.3
|
0.5
|
|
C
|
A:VAL746
|
4.7
|
14.9
|
1.0
|
|
CD1
|
A:LEU873
|
4.7
|
20.7
|
1.0
|
|
SD
|
A:MET742
|
4.7
|
19.8
|
1.0
|
|
N
|
A:MET745
|
4.8
|
14.3
|
1.0
|
|
C13
|
A:97A1004
|
5.0
|
17.6
|
0.5
|
|
Fluorine binding site 5 out
of 6 in 5v8q
Go back to
Fluorine Binding Sites List in 5v8q
Fluorine binding site 5 out
of 6 in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
 Mono view
 Stereo pair view
|
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III within 5.0Å range:
|
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1004
b:18.3
occ:0.50
|
F23
|
A:97A1004
|
0.0
|
18.3
|
0.5
|
|
F23
|
A:97A1004
|
0.5
|
19.6
|
0.5
|
|
C20
|
A:97A1004
|
1.3
|
18.4
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.3
|
0.5
|
|
F22
|
A:97A1004
|
1.8
|
18.8
|
0.5
|
|
F21
|
A:97A1004
|
2.3
|
18.3
|
0.5
|
|
F22
|
A:97A1004
|
2.3
|
17.9
|
0.5
|
|
F21
|
A:97A1004
|
2.3
|
17.4
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.2
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.5
|
0.5
|
|
C16
|
A:97A1004
|
2.6
|
18.0
|
0.5
|
|
C16
|
A:97A1004
|
2.7
|
20.0
|
0.5
|
|
C15
|
A:97A1004
|
2.9
|
17.9
|
0.5
|
|
C15
|
A:97A1004
|
2.9
|
17.8
|
0.5
|
|
N17
|
A:97A1004
|
3.0
|
19.7
|
0.5
|
|
N17
|
A:97A1004
|
3.1
|
23.4
|
0.5
|
|
CB
|
A:MET749
|
3.3
|
15.4
|
1.0
|
|
C19
|
A:97A1004
|
3.6
|
17.9
|
0.5
|
|
CG
|
A:MET749
|
3.6
|
16.5
|
1.0
|
|
C19
|
A:97A1004
|
3.6
|
18.1
|
0.5
|
|
CD1
|
A:PHE764
|
3.7
|
15.2
|
1.0
|
|
O
|
A:MET745
|
3.7
|
16.3
|
1.0
|
|
CE1
|
A:PHE764
|
3.7
|
16.7
|
1.0
|
|
CE
|
A:MET749
|
3.8
|
18.8
|
1.0
|
|
C
|
A:MET745
|
4.0
|
14.5
|
1.0
|
|
CA
|
A:VAL746
|
4.0
|
15.2
|
1.0
|
|
N
|
A:VAL746
|
4.2
|
14.2
|
1.0
|
|
C14
|
A:97A1004
|
4.3
|
17.8
|
0.5
|
|
C14
|
A:97A1004
|
4.3
|
16.2
|
0.5
|
|
CB
|
A:MET745
|
4.3
|
16.4
|
1.0
|
|
SD
|
A:MET749
|
4.5
|
17.6
|
1.0
|
|
CG2
|
A:VAL746
|
4.6
|
15.5
|
0.3
|
|
CB
|
A:VAL746
|
4.6
|
17.7
|
0.7
|
|
CG2
|
A:VAL746
|
4.7
|
18.4
|
0.7
|
|
C12
|
A:97A1004
|
4.7
|
18.1
|
0.5
|
|
CA
|
A:MET749
|
4.8
|
14.3
|
1.0
|
|
C12
|
A:97A1004
|
4.8
|
18.3
|
0.5
|
|
CA
|
A:MET745
|
4.8
|
15.1
|
1.0
|
|
O
|
A:HOH1195
|
4.8
|
17.2
|
1.0
|
|
SD
|
A:MET787
|
4.8
|
23.4
|
1.0
|
|
CB
|
A:VAL746
|
4.9
|
15.8
|
0.3
|
|
CG
|
A:PHE764
|
4.9
|
15.1
|
1.0
|
|
CZ
|
A:PHE764
|
4.9
|
16.6
|
1.0
|
|
NH2
|
A:ARG752
|
5.0
|
16.2
|
1.0
|
|
C
|
A:VAL746
|
5.0
|
14.9
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5v8q
Go back to
Fluorine Binding Sites List in 5v8q
Fluorine binding site 6 out
of 6 in the Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III
 Mono view
 Stereo pair view
|
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms): Part III within 5.0Å range:
|
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1004
b:19.6
occ:0.50
|
F23
|
A:97A1004
|
0.0
|
19.6
|
0.5
|
|
F23
|
A:97A1004
|
0.5
|
18.3
|
0.5
|
|
C20
|
A:97A1004
|
1.4
|
18.4
|
0.5
|
|
C20
|
A:97A1004
|
1.5
|
18.3
|
0.5
|
|
F21
|
A:97A1004
|
2.1
|
18.3
|
0.5
|
|
F22
|
A:97A1004
|
2.3
|
18.8
|
0.5
|
|
F21
|
A:97A1004
|
2.3
|
17.4
|
0.5
|
|
C18
|
A:97A1004
|
2.4
|
17.2
|
0.5
|
|
C18
|
A:97A1004
|
2.5
|
17.5
|
0.5
|
|
F22
|
A:97A1004
|
2.6
|
17.9
|
0.5
|
|
C16
|
A:97A1004
|
2.8
|
18.0
|
0.5
|
|
C16
|
A:97A1004
|
2.9
|
20.0
|
0.5
|
|
C15
|
A:97A1004
|
3.0
|
17.9
|
0.5
|
|
C15
|
A:97A1004
|
3.0
|
17.8
|
0.5
|
|
CE1
|
A:PHE764
|
3.2
|
16.7
|
1.0
|
|
N17
|
A:97A1004
|
3.2
|
19.7
|
0.5
|
|
CD1
|
A:PHE764
|
3.2
|
15.2
|
1.0
|
|
N17
|
A:97A1004
|
3.3
|
23.4
|
0.5
|
|
CB
|
A:MET749
|
3.4
|
15.4
|
1.0
|
|
CG
|
A:MET749
|
3.4
|
16.5
|
1.0
|
|
CE
|
A:MET749
|
3.4
|
18.8
|
1.0
|
|
C19
|
A:97A1004
|
3.5
|
17.9
|
0.5
|
|
C19
|
A:97A1004
|
3.6
|
18.1
|
0.5
|
|
O
|
A:MET745
|
4.1
|
16.3
|
1.0
|
|
SD
|
A:MET749
|
4.2
|
17.6
|
1.0
|
|
C14
|
A:97A1004
|
4.3
|
17.8
|
0.5
|
|
CA
|
A:VAL746
|
4.3
|
15.2
|
1.0
|
|
C14
|
A:97A1004
|
4.3
|
16.2
|
0.5
|
|
CZ
|
A:PHE764
|
4.4
|
16.6
|
1.0
|
|
C
|
A:MET745
|
4.5
|
14.5
|
1.0
|
|
CG
|
A:PHE764
|
4.5
|
15.1
|
1.0
|
|
SD
|
A:MET787
|
4.6
|
23.4
|
1.0
|
|
N
|
A:VAL746
|
4.6
|
14.2
|
1.0
|
|
C12
|
A:97A1004
|
4.7
|
18.1
|
0.5
|
|
C12
|
A:97A1004
|
4.8
|
18.3
|
0.5
|
|
CG2
|
A:VAL746
|
4.8
|
18.4
|
0.7
|
|
CG2
|
A:VAL746
|
4.8
|
15.5
|
0.3
|
|
CB
|
A:MET745
|
4.9
|
16.4
|
1.0
|
|
CB
|
A:VAL746
|
4.9
|
17.7
|
0.7
|
|
CA
|
A:MET749
|
4.9
|
14.3
|
1.0
|
|
Reference:
K.Aikawa,
M.Asano,
K.Ono,
N.Habuka,
J.Yano,
K.Wilson,
H.Fujita,
H.Kandori,
T.Hara,
M.Morimoto,
T.Santou,
M.Yamaoka,
M.Nakayama,
A.Hasuoka.
Synthesis and Biological Evaluation of Novel Selective Androgen Receptor Modulators (Sarms) Part III: Discovery of 4-(5-Oxopyrrolidine-1-Yl)Benzonitrile Derivative 2F As A Clinical Candidate. Bioorg. Med. Chem. V. 25 3330 2017.
ISSN: ESSN 1464-3391
PubMed: 28454849
DOI: 10.1016/J.BMC.2017.04.018
Page generated: Thu Aug 1 16:01:07 2024
|
